Atopic Dermatitis

Etrasimod Demonstrates New Safety, Efficacy Data for AD in Phase 2 Study
May 05, 2021

A study presented at the American Academy of Dermatology Virtual Meeting Experience 2021 exhibited new safety and efficacy data for etrasimod as a potential treatment for atopic dermatitis.

Tralokinumab Safe, Effective for Long-Term Treatment of Atopic Dermatitis
May 03, 2021

Interim analysis of data from the ECZTEND study evaluating the long-term safety, efficacy, and tolerability of tralokinumab for treatment of atopic dermatitis was presented at AAD VMX 2021.

Abrocitinib Effective as Flexible Dose for Atopic Dermatitis
April 30, 2021

A phase 3 trial found different doses of abrocitinib demonstrated efficacy as a treatment for atopic dermatitis.